16 October 2023 | News
In the event of an outbreak, IQVIA will provide surge capacity to support clinical trial sites
IQVIA, a leading global provider of advanced analytics, technology solutions, and clinical research services, and The Coalition for Epidemic Preparedness Innovations (CEPI) have announced a strategic collaboration to advance the 100 Days Mission.
In conjunction with national and regional collaborators, CEPI and IQVIA will aim to enhance the world’s preparedness to rapidly conduct life-saving clinical research for vaccines and other biological countermeasures against emerging infectious diseases.
CEPI will harness IQVIA’s extensive clinical research expertise and innovative solutions, as well as its global reach, to support its goal of strengthening pandemic preparedness clinical research capability in Low- and Middle-Income Countries (LMICs) to accelerate vaccine development when faced with future viral threats.
As part of its mission to enable faster and more equitable responses to future viral threats, CEPI will support the establishment of regional consortia, comprised of and led by national and regional stakeholders, to bolster research preparedness across LMICs. The regional consortia will identify gaps and needs in regional clinical research capability, and oversee the building of sustainable research capacity that can be swiftly put into action to respond to infectious disease outbreaks.
IQVIA will play a crucial role as a global service provider, utilising its global reach and bandwidth to support the regional consortia and CEPI to fill gaps that will accelerate the generation of high-quality data during an outbreak response.